Stock research firms currently have a positive stance on shares of Axon Enterprise, Inc. (:AAXN). Analysts are projecting that the stock will reach $30.83 on a short term (1 year) basis.
The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.10. This is based on the research brokerage reports taken into consideration by Thomson Reuters.
At the time of writing, the stock was trading at $26.46. This represents a change from most recent open price of 3.36%. In terms of performance, year to date, the stock is 4.83%. The monthly stock performance comes in at 5.30%. For the quarter, shares are performing at 10.77%. Weekly performance analysis shows the equity at 5.00%.
In taking a look at technical levels, shares are trading 8.51% away from the 50 day simple moving average and 6.96% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -12.24% away from it’s 52- week high and 24.93% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Axon Enterprise, Inc.’s RSI stands at 70.45. In looking at volatility levels, the shares saw weekly volatility of 2.66% and 2.10% over the past month.
Brokerage firms currently have a positive stance on shares of Axsome Therapeutics, Inc. (:AXSM). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.50. Those same analysts are projecting that the stock will reach $18.75 on a short term basis.
Axsome Therapeutics, Inc. (:AXSM) shares typically trade an average volume of 281.62 and institutions hold 32.90% of the total shares.
We see here that the stock is 17.04% away from the 20-Day Simple Moving Average. Their 50-Day Simple Moving Average is a difference of 19.56% from current levels. Further back, their 200-Day Simple Moving Average is -13.78% difference from today’s price. Currently, the stock is 2.23% from its 50-Day High and 35.89% from the 50-day low.
Axsome Therapeutics, Inc. (:AXSM)‘s stock has performed at -31.85%. Breaking that down further, it has performed 13.58% for the week, 21.05% for the month, 4.55% over the last quarter, -24.59% for the past half-year and -27.44% for this last year.